椎體成形術市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、應用、適應症、最終用戶、地區和競爭格局分類），2021-2031年

全球椎體成形術市場預計將從 2025 年的 7.3485 億美元成長到 2031 年的 10.7285 億美元，複合年成長率為 6.51%。

椎體成形術是一種微創技術，透過將一個特殊球囊插入骨折的椎體，形成一個空腔，然後注入骨水泥，以恢復椎體的高度和穩定性。市場成長的主要驅動力是全球人口老化導致的脊椎骨折發生率上升以及由此引發的骨質疏鬆症增加。此外，由於微創治療方法具有住院時間短、恢復快等優勢，人們越來越傾向於選擇微創治療而非傳統開放性手術。

儘管有這些成長要素，但市場仍面臨許多障礙，例如嚴格的報銷通訊協定和高昂的手術費用，這限制了經濟拮据的醫療機構中患者的就醫途徑。國際骨質疏鬆症基金會指出，到2024年，55歲及以上人口每年將發生多達3,700萬例脆性骨折，凸顯了骨折管理解決方案的巨大臨床需求。然而，儘管發病率如此之高，但經濟障礙和保險覆蓋範圍的限制仍然是限制市場更廣泛發展和擴張的重大障礙。

市場促進因素

椎體成形系統和骨水泥技術的進步顯著推動了市場成長，提高了手術安全性和臨床療效。製造商正致力於研發高黏度骨水泥和先進的球囊導管，以確保精準恢復椎體高度，同時最大限度地降低滲漏風險，從而增強外科醫生的信心並促進其應用。此外，射頻靶向增強技術和可操控球囊的整合最佳化了手術流程，使這些微創手術比傳統方法更具吸引力。史賽克公司2025年2月發布的報告也反映了這一需求，該報告指出，在專業脊椎技術的強勁應用推動下，該公司脊椎介入業務在2024年實現了超過10%的有機銷售成長。

同時，骨質疏鬆症和椎體壓迫性骨折的日益普遍，正成為全球市場擴張的潛在驅動力。隨著人口老化，低骨骼密度現像日益普遍，導致易發生脆性骨折且需要手術固定的患者群體不斷擴大。美國預防服務工作小組（USPSTF）在2025年1月指出，65歲以上女性中，骨質疏鬆症的盛行率為27.1%。這項數據與醫療機構優先考慮早期療育導致的手術量增加趨勢直接相關。這種需求促進了該行業的財務健康發展，Merit Medical Systems公司2024會計年度的年收入達到13.57億美元，較上年成長7.9%，便印證了這一點。這項成長主要得益於該公司介入器材產品組合的強勁表現。

市場挑戰

嚴格的報銷政策和高昂的手術費用嚴重阻礙了椎體成形術市場的發展。醫療機構經常面臨複雜的核准流程和椎體增強手術支付標準的下降，這在注重成本的醫療環境下阻礙了此類治療方法的廣泛應用。當保險覆蓋範圍受限或被拒絕時，經濟負擔往往會轉移到醫療機構和患者身上，導致擇期手術數量減少。這些經濟壓力迫使醫院選擇臥床休息和藥物止痛等保守治療，而非微創手術。

這些財務限制在各大醫療系統中尤為突出，直接影響脊椎專科手術的盈利和生存能力。 2024年，美國醫學會（AMA）報告稱，聯邦醫療保險（Medicare）醫生收費標準下調了3.39%，進一步壓縮了開展椎體成形術的醫療機構的營運利潤。此類財務限制使得醫療機構難以投資必要的設備，並降低了病患獲得先進治療的機會。因此，許多有效的臨床適應症往往被轉移到成本較低的療法上，直接抑制了整體市場收入的成長。

市場趨勢

脊椎增強手術向門診手術中心 (ASC) 的轉移，代表著一項由對具成本效益門診醫療服務的需求驅動的重大結構性變革。由於椎體成形術屬於微創手術，支付方正積極推動將病例從傳統醫院轉移到專科機構，以降低營運成本並提高病患處理效率。門診手術中心的運作效率（更高的病例量和更快的出院流程）也支持了這一轉變。 Surgery Partners, Inc. 正是這一趨勢取得財務成功的典型例證。該公司於 2025 年 3 月公佈，2024 會計年度營收達 31 億美元（較上年成長 13.5%），並將這一成長歸功於短期住院手術機構的戰略擴張。

同時，術中3D透視和導航技術的引入，透過滿足骨水泥注射過程中對精準度的關鍵需求，重新定義了手術標準。與標準的2D成像不同，這些先進系統能夠即時、多維地可視化脊椎解剖結構，顯著降低骨水泥滲漏的風險，並減少手術團隊的輻射曝射量。這項技術的整合提高了臨床醫生對複雜骨折治療的信心，並促進了增強療法的更廣泛應用。 2025年2月，Medtronic公佈其顱脊椎技術部門的營收為12.5億美元，年增3.8%，主要得益於公司底層技術生態系的強勁應用。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球椎體成形術市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品分類（球囊導管、骨骼通路裝置、骨水泥注射產品、骨水泥、骨水泥混合系統、器械）
  • 依應用領域（椎體矯正、脊椎骨折、脊椎後凸）
  • 依適應症（骨質疏鬆症、其他）
  • 依最終使用者（醫院/診所、門診手術中心、其他）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美椎體成形術市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲椎體成形術市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區椎體成形術市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲椎體成形術市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲椎體成形術市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球椎體成形術市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Stryker Corporation
• Medtronic plc
• Smith+Nephew Plc
• Microport Scientific Corporation
• DePuy Synthes Companies
• IZI Medical Products, LLC（Halma plc）
• Merit Medical Systems, Inc.
• Joline GmbH & Co. KG
• Hensler Surgical Products LLC
• Jiangsu Changmei Medtech Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Kyphoplasty Market is projected to expand from USD 734.85 Million in 2025 to USD 1072.85 Million by 2031, reflecting a compound annual growth rate of 6.51%. Kyphoplasty involves a minimally invasive technique wherein a specialized balloon is inserted into a fractured vertebra to create a cavity, which is then filled with bone cement to restore height and stability. Market growth is primarily driven by a globally aging population and a corresponding rise in osteoporosis, which increases the incidence of spinal fractures. Additionally, the shift toward minimally invasive options over traditional open surgeries continues to gain traction due to advantages such as shorter hospital stays and accelerated recovery times.

Despite these growth drivers, the market encounters significant hurdles related to strict reimbursement protocols and the substantial costs of procedures, which limit patient access in economically constrained healthcare environments. The International Osteoporosis Foundation noted in 2024 that up to 37 million fragility fractures occur annually in individuals over the age of 55, underscoring a massive clinical need for fracture management solutions. However, even with this high incidence rate, financial barriers and coverage restrictions continue to pose significant obstacles to broader market development and expansion.

Market Driver

Technological advancements in kyphoplasty systems and bone cements are significantly propelling market growth by improving procedural safety and clinical results. Manufacturers are increasingly focusing on developing high-viscosity cements and advanced balloon catheters that minimize leakage risks while ensuring precise vertebral height restoration, thereby boosting surgeon confidence and adoption. Furthermore, the integration of radiofrequency-targeted augmentation and steerable balloons has optimized surgical workflows, making these minimally invasive interventions more appealing than traditional methods. This demand is reflected in Stryker's February 2025 report, which noted that their Interventional Spine business achieved over 10% organic sales growth in 2024, driven by the strong uptake of these specialized spine technologies.

Simultaneously, the rising prevalence of osteoporosis and vertebral compression fractures acts as a fundamental catalyst for global market expansion. As the population ages, low-bone-density conditions become more common, resulting in a larger pool of patients susceptible to fragility fractures that require surgical stabilization. The U.S. Preventive Services Task Force highlighted in January 2025 that osteoporosis affects 27.1% of women aged 65 and older, a statistic that correlates directly with increased procedural volumes as providers prioritize early intervention. This demand contributes to sector financial health, as evidenced by Merit Medical Systems reporting a 2024 annual revenue of $1.357 billion, a 7.9% year-over-year increase largely supported by its interventional device portfolio.

Market Challenge

Stringent reimbursement policies and high procedural costs constitute substantial barriers to the growth of the kyphoplasty market. Healthcare providers frequently face complicated approval processes and declining payment rates for vertebral augmentation, which discourages the widespread adoption of these treatments in cost-conscious settings. When insurance coverage is restricted or denied, the financial burden often shifts to medical facilities or patients, leading to a decline in elective procedure volumes. Consequently, economic pressures force hospitals to favor conservative management options, such as bed rest and pain medication, rather than utilizing minimally invasive surgical interventions.

These financial constraints are intensifying across major healthcare systems, directly impacting the profitability and viability of offering specialized spinal surgeries. In 2024, the American Medical Association reported a 3.39 percent reduction in Medicare physician payment rates, which further compresses operating margins for practices performing kyphoplasty. Such fiscal tightening limits the ability of healthcare providers to invest in necessary equipment and reduces patient access to advanced care. As a result, valid clinical candidates are often diverted toward lower-cost therapies, directly impeding total market revenue growth.

Market Trends

The migration of vertebral augmentation procedures to Ambulatory Surgical Centers (ASCs) represents a significant structural shift driven by the demand for cost-effective outpatient care. Because kyphoplasty is a minimally invasive procedure, payers are actively moving these cases from traditional hospitals to specialized facilities to lower overhead costs and improve patient throughput. This transition is supported by the operational efficiency of ASCs, which allow for higher case volumes and expedited discharge processes. The financial success of this trend is illustrated by Surgery Partners, which reported in March 2025 a total annual revenue of $3.1 billion for 2024, a 13.5% increase year-over-year attributed to the strategic expansion of short-stay surgical facilities.

Concurrently, the incorporation of intraoperative 3D fluoroscopy and navigation technologies is redefining procedural standards by addressing the critical need for precision during cement delivery. Unlike standard 2D imaging, these advanced systems provide real-time, multi-dimensional visualization of vertebral anatomy, significantly reducing the risk of cement leakage and lowering radiation exposure for the surgical team. This technological integration enhances clinical confidence in treating complex fractures, promoting broader utilization of augmentation therapies. In February 2025, Medtronic reported that its Cranial and Spinal Technologies division generated $1.25 billion in revenue, a 3.8% year-over-year increase driven primarily by the robust adoption of its enabling technology ecosystem.

Key Market Players

• Stryker Corporation
• Medtronic plc
• Smith + Nephew Plc
• Microport Scientific Corporation
• DePuy Synthes Companies
• IZI Medical Products, LLC (Halma plc)
• Merit Medical Systems, Inc.
• Joline GmbH & Co. KG
• Hensler Surgical Products LLC
• Jiangsu Changmei Medtech Co., Ltd.

Report Scope

In this report, the Global Kyphoplasty Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Kyphoplasty Market, By Product

• Balloon Catheters
• Bone Access Devices
• Cement Application Products
• Bone Cement
• Cement Mixing System
• Instruments

Kyphoplasty Market, By Application

• Vertebral Alignment Restoration
• Spinal Fractures
• Kyphosis

Kyphoplasty Market, By Indication

• Osteoporosis
• Others

Kyphoplasty Market, By End User

• Hospitals & Clinics
• Ambulatory Surgical Centres
• Others

Kyphoplasty Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Kyphoplasty Market.

Available Customizations:

Global Kyphoplasty Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Kyphoplasty Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Balloon Catheters, Bone Access Devices, Cement Application Products, Bone Cement, Cement Mixing System, Instruments)
  • 5.2.2. By Application (Vertebral Alignment Restoration, Spinal Fractures, Kyphosis)
  • 5.2.3. By Indication (Osteoporosis, Others)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Kyphoplasty Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Indication
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Kyphoplasty Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Indication
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Kyphoplasty Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Indication
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Kyphoplasty Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Indication
      • 6.3.3.2.4. By End User

7. Europe Kyphoplasty Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Indication
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Kyphoplasty Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Indication
      • 7.3.1.2.4. By End User
  • 7.3.2. France Kyphoplasty Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Indication
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Kyphoplasty Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Indication
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Kyphoplasty Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Indication
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Kyphoplasty Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Indication
      • 7.3.5.2.4. By End User

8. Asia Pacific Kyphoplasty Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Indication
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Kyphoplasty Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Indication
      • 8.3.1.2.4. By End User
  • 8.3.2. India Kyphoplasty Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Indication
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Kyphoplasty Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Indication
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Kyphoplasty Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Indication
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Kyphoplasty Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Indication
      • 8.3.5.2.4. By End User

9. Middle East & Africa Kyphoplasty Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Indication
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Kyphoplasty Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Indication
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Kyphoplasty Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Indication
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Kyphoplasty Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Indication
      • 9.3.3.2.4. By End User

10. South America Kyphoplasty Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Indication
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Kyphoplasty Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Indication
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Kyphoplasty Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Indication
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Kyphoplasty Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Indication
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Kyphoplasty Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Stryker Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medtronic plc
• 15.3. Smith + Nephew Plc
• 15.4. Microport Scientific Corporation
• 15.5. DePuy Synthes Companies
• 15.6. IZI Medical Products, LLC (Halma plc)
• 15.7. Merit Medical Systems, Inc.
• 15.8. Joline GmbH & Co. KG
• 15.9. Hensler Surgical Products LLC
• 15.10. Jiangsu Changmei Medtech Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer